Helping Children Receive an Earlier Autism Diagnosis

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX AA test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Posters & Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]

Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018. NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States.[…]

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes [Biological Psychiatry, 2018]

Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder ASD is currently diagnosed based on behavioral characteristics exhibited by an affected child. While specialist clinicians are able to confidently diagnose children as young as 24 months, the average age of diagnosis in the United States is over[…]

NEWS

NeuroPointDX Announces Commercialization of First Objective Blood Test to Aid Earlier Diagnosis of Autism Spectrum Disorder

NeuroPointDX Announces Commercialization of First Objective Blood Test to Aid Earlier Diagnosis of Autism Spectrum Disorder New test identifies metabolic subtypes in about 30% of children with autism spectrum disorder (ASD), based on findings from the largest clinical study of the metabolism of children with ASD Screens children as young as 18 months Test also[…]